EUVIMEDEUVIMED entdecken
Crossref

Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications

Mattis Bertlich iD, Daniela Hartmann, Saskia Freytag, Lars E French, Eva Oppel

British Journal of Dermatology · 18.11.2024 · 191 (6) · 1000-1007

DOI: 10.1093/bjd/ljae290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 15.07.2024. Verfasst von Mattis Bertlich und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany, Frauenlobstr. 9-11, D-80337 Munich,Germany. Hauptthemen laut MEDLINE: Hyaluronoglucosaminidase, Skin Tests. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Department of Dermatology, LMU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyaluronidase is an ubiquitous enzyme, present, among others, in hymenoptera venom and in medical formulations. The latter include use as an emergency treatment or to correct undesired outcomes of medical and aesthetic procedures using hyaluronic acid fillers.

Objectives

By performing detailed allergy work-ups including skin-prick tests (SPTs) we investigated whether patients with a history of allergic reaction to hymenoptera venom are also sensitized to medical grade hyaluronidase.

Methods

Ninety patients with a history of type-1 reaction to hymenoptera venom with and without a history of previous specific venom immunotherapy were included in the study. All underwent SPTs for medical hyaluronidase. All patients also underwent serological analysis for Api m2, the only commercially available IgE test for a hymenoptera hyaluronidase.

Results

Of the 90 patients with previous type-1 reactions to hymenoptera venom hyaluronidase included in the study, 60 had undergone previous venom immunotherapy; 30 did not. The majority (73 of 90) were allergic to wasps, followed by honeybees (14 of 90) and three were allergic to both. Neither patients having undergone previous immunotherapy nor those allergic to bees showed positive SPTs to medical hyaluronidase. Of those with a wasp allergy and naïve to immunotherapy, over 20% (5 of 23) showed positive SPTs to medical hyaluronidase. Healthy controls (0 of 30) without previous allergic reactions to hymenoptera did not show positive SPTs to medical hyaluronidase.

Conclusions

Sensitization to hyaluronidase is most common in wasp-allergic patients who have not had previous specific immunotherapy. As allergic reactions to medical hyaluronidase are reported to be scarce, this group is probably at the highest risk to develop anaphylaxis to medical hyaluronidase. While all patients with untreated anaphylaxis to hymenoptera venom should consult an allergy specialist, it is particularly important that those with untreated wasp allergies seek specialist advice before treatment with medical hyaluronidase is initiated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyaluronoglucosaminidaseSkin TestsHumansAnimalsFemaleMaleAdultMiddle AgedHymenopteraYoung AdultImmunoglobulin EAgedArthropod VenomsAdolescentInsect Bites and Stings

Substanzen

HyaluronoglucosaminidaseImmunoglobulin EArthropod Venoms

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany, Frauenlobstr. 9-11, D-80337 Munich,Germany.
  • The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Melbourne 3052, VIC, Australia.

ORCID-Profile: Mattis Bertlich

Förderung

  • Department of Dermatology
  • LMU

Zitieren

APA

Bertlich, M., Hartmann, D., Freytag, S., French, L. E., & Oppel, E. (2024). Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications. British Journal of Dermatology, 191(6), 1000-1007. https://doi.org/10.1093/bjd/ljae290

Vancouver

Bertlich M, Hartmann D, Freytag S, French LE, Oppel E. Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications. British Journal of Dermatology. 2024;191(6):1000-1007. doi:10.1093/bjd/ljae290

BibTeX
@article{Bertlich2024,
  author = {Bertlich, Mattis and Hartmann, Daniela and Freytag, Saskia and French, Lars E and Oppel, Eva},
  title = {Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications},
  journal = {British Journal of Dermatology},
  year = {2024},
  volume = {191},
  number = {6},
  pages = {1000--1007},
  doi = {10.1093/bjd/ljae290}
}
Kostenlos starten →